tirzepatide microdose protocol I'm starting a new longevity protocol: microdosing Tirzepatide, a dual GLP-1/GIP receptor agonist. Here is the existing evidence, my protocol, measurement plan, and what I expect to achieve by this intervention. 🧵 Compounded GLP Weight Loss |

Its important to understand these factors and discuss them with a healthcare provider before starting the medication

443 Unfortunately, the trial results showed that CSL112 did not significantly reduce the composite primary endpoint, challenging the longstanding hypothesis that direct enhancement of HDL function would provide clinical benefits

Accu-Chek Accu-Chek is a trusted brand for diabetic supplies that Medicare covers

Do we know if any of them actually had a deficiency

Both figures come from peer-reviewed NEJM trials of FDA-approved active ingredients in controlled settings - not from compounded formulations or any specific platform

H., Knudson, G., Leibowitz, S., MeyerBahlburg, H